Recent Acquisition Opportunity Following Eximia Research's acquisition of Tidewater Clinical Research in August 2024, there is potential for cross-selling and collaborative opportunities related to women's health and ophthalmology clinical trials in the Hampton Roads/Eastern Virginia region.

Regional Expertise Tidewater's specialized focus on the Hampton Roads area and its involvement in niche markets such as women's health and ophthalmology present opportunities to expand services in similar regional markets or specialized therapeutic areas.

Niche Clinical Focus With a history of providing investigational treatments and fostering private practitioner involvement, the company is well-positioned to attract sponsors seeking tailored, reliable clinical trial data within boutique or specialized segments.

Growth Possibilities As part of a larger corporate structure now under Eximia Research, Tidewater has potential access to broader networks and funding avenues, enabling sales teams to promote expanded service offerings or integrated solutions.

Market Position Despite a small team, Tidewater operates in a competitive environment with larger CROs; leveraging its regional presence and specialized clinical focus can help differentiate its offerings to attract new sponsor partnerships.